A new diagnostic procedure to detect unknown transthyretin (TTR) mutations in familial amyloidotic polyneuropathy (FAP).
Two patients with amyloidosis caused by transthyretin (TTR) were investigated by immunohistopathologic, mass spectrometric, and molecular genetic methods. After confirming the immunoreactivity of TTR in the amyloid deposits using anti-TTR polyclonal antibody, a new method: centrifugal concentration and electrospray ionization mass spectrometry (ESI-MS) was employed to detect the variant TTR in the serum. Only 50 microl of the serum and 30 microl of the anti-TTR antibody were needed for the analysis. After incubation with the antibody, the samples were passed through a 1000 kDa cut off centrifugal concentrator to retain the antibody, thereafter, the filtrate was analyzed by ESI-MS. Several forms of normal and variant TTR were detected in the serum samples: unconjugated TTR, cysteine and cysteine-glycine conjugated TTR. In the patients, a variant form of TTR was detected with a 26.0 Da higher molecular weight than that of normal TTR. Single-strand conformation polymorphism (SSCP) and direct sequence analysis confirmed the presence of a one-base substitution situated at the codon 50 from AGT (Ser) to ATT (Ile) in both patients, that corresponded to the increased molecular weight of 26.0. The present diagnostic procedure demonstrates the usefulness of both ESI-MS and SSCP to screen for TTR related amyloidosis rapidly. Moreover, the DNA samples obtained from the band showing abnormal electrophoretic migration pattern in SSCP, facilitate the direct sequence analysis to detect the unknown mutation, and the observed shift in molecular weight of the variant TTR in ESI-MS confirms the base substitution.
Yamashita
T
T
First Department of Internal Medicine, Kumamoto University School of Medicine, Honjo 1-1-1, Kumamoto, Japan.
Ando
Y
Y
Bernt Suhr
O
O
Nakamura
M
M
Sakashita
N
N
Ohlsson
P I
PI
Terazaki
H
H
Obayashi
K
K
Uchino
M
M
Ando
M
M
D019943:Amino Acid Substitution; D000682:Amyloid / Q000737:chemistry; D017772:Amyloid Neuropathies / Q000175:diagnosis* / Q000235:genetics; D002498:Centrifugation; D004396:Coloring Agents; D003224:Congo Red; D003545:Cysteine / Q000032:analysis; D005091:Exons / Q000235:genetics; D005260:Female; D005820:Genetic Testing / Q000379:methods*; D005998:Glycine / Q000032:analysis; D006801:Humans; D008297:Male; D013058:Mass Spectrometry; D008875:Middle Aged; D008970:Molecular Weight; D017354:Point Mutation; D018807:Polymorphism, Single-Stranded Conformational; D011228:Prealbumin / Q000032:analysis / Q000737:chemistry / Q000235:genetics*
D000682:Amyloid; D004396:Coloring Agents; D011228:Prealbumin; D003224:Congo Red; D003545:Cysteine; D005998:Glycine